The Food and Drug Administration has warned people about the many dangers of buying medications from foreign pharmacies over the Internet. While some sites might offer high-quality medicines, there are plenty that sell bogus and potentially dangerous products.
Locavores, a word with you. Local food may be gaining traction in all kinds of ways, but a report out today from the Institute of Medicine serves as a stark reminder of just how globalized our food system truly is.
Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.
U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.
Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.
A nonprofit foundation set up to support scientific research of interest to the Food and Drug Administration is finally starting to take off after years of struggling financially — and it's about to get some long-promised funding from the FDA.
But some critics worry that this foundation, which will also raise money from private sources including industry, could provide a way for the food and medical industries to sway FDA decisions.
The U.S. Food and Drug Administration has denied a call to ban the plastic additive BPA from food packaging. The action comes after government scientists found little reason to think people are being harmed by the chemical.
The FDA was responding to a petition from the Natural Resources Defense Council, which called for the ban on BPA, also known as bisphenol A, from any use where it comes in contact with food.